Výsledky vyhledávání - "Darren L. Culshaw"

Tedizolid and Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections of the Lower Extremity versus Non–Lower-Extremity Infections

Autor: Carisa De Anda, Steven Anuskiewicz, Warren S. Joseph, Philippe Prokocimer, Darren L. Culshaw

Publikováno v: Journal of the American Podiatric Medical Association. 107:264-271

Background: Tedizolid phosphate, the prodrug of the oxazolidinone tedizolid, has been approved in a number of countries, including the United States, those in the European Union, and Canada, for treatment of patients with acute bacterial skin and ski

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::255161000b2fd27c2dd4c6450e411c2a
https://doi.org/10.7547/15-218

Zobrazit plný text záznamu

Duration of prior vancomycin therapy and subsequent daptomycin treatment outcomes in methicillin-resistant Staphylococcus aureus bacteremia

Autor: Kenneth C. Lamp, Thomas P. Lodise, Min J. Yoon, Darren L. Culshaw

Publikováno v: Diagnostic Microbiology and Infectious Disease. 83(2):193-197

The association between varying durations of previous vancomycin therapy and subsequent daptomycin success rates was evaluated in a subset of patients with methicillin-resistant Staphylococcus aureus bacteremia from the Cubicin® Outcomes Registry an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::893800b54706723ddad127f561f8339c

Zobrazit plný text záznamu

2381. Ceftolozane/Tazobactam in the Treatment of Experimental Pseudomonas aeruginosa Pneumonia in Persistently Neutropenic Rabbits: Impact on Strains With Genetically Defined Resistance

Autor: Povilas Kavaliauskas, Michael J. Satlin, Thein Aung, Wai Phyo Thi, Vidmantas Petraitis, Luzelena Caro, Ethan Naing, Ruta Petraitiene, Thomas J. Walsh, Darren L. Culshaw, C Andrew DeRyke

Publikováno v: Open Forum Infectious Diseases

Background Pseudomonas pneumonia is a life-threatening infection with high mortality, particularly in neutropenic patients. The efficacy of current antimicrobial therapy with extended spectrum penicillins (ESPs) and anti-pseudomonal cephalosporins (A

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4dd96845f44e79f1b904c148af22d34
http://europepmc.org/articles/PMC6255582

Zobrazit plný text záznamu

Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC1 mg/L: A Multicenter Evaluation

Autor: Thomas P. Lodise, Marcus J. Zervos, Katherine Reyes, James A. McKinnell, Karri A. Bauer, Romic Eskandarian, Kimberly D Leuthner, Darren L. Culshaw, Joyce Bensman, Annie Wong-Beringer, Saira B. Chaudhry, Winter J. Smith, Kenneth C. Lamp, Robert Adamson, Pamela A. Moise, Michael Virata, Debra A. Goff

Publikováno v: Clinical therapeutics. 38(1)

Purpose Clinical studies comparing vancomycin with alternative therapy for methicillin-resistant Staphylococcus aureus (MRSA) bacteremia are limited. The objective of this study was to compare outcomes of early daptomycin versus vancomycin treatment

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7b26c20804833a3b6b510e09727c882
https://pubmed.ncbi.nlm.nih.gov/26585355

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání